SGLT2 inhibitors: PRAC makes recommendations to minimise risk of diabetic ketoacidosis

View source ↗

Summary

PRAC recommends measures to minimize the risk of diabetic ketoacidosis with SGLT2 inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)